LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Akero Therapeutics (NASDAQ: AKRO)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ AKRO Akero Therapeutics
Young Jonathan / officer: Chief Operating Officer
01/02/2025
Sell
$28.03
10,000
$280K
218,083
NASDAQ AKRO Akero Therapeutics
Young Jonathan / officer: Chief Operating Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ AKRO Akero Therapeutics
Lamy Patrick / officer: Senior VP, Commercial Strategy
12/16/2024
Buy
$29.23
52,100
$1.523M
52,100
NASDAQ AKRO Akero Therapeutics
Lamy Patrick / officer: Senior VP, Commercial Strategy
12/16/2024
Sell
$29.13
1,000
$29K
34,258
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
12/16/2024
Buy
$21.10
9,074
$191K
104,722
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
12/16/2024
Sell
$29.11
9,074
$264K
95,648
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
12/16/2024
Sell
$21.10
9,074
$191K
20,000
NASDAQ AKRO Akero Therapeutics
White William Richard / officer: Chief Financial Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ AKRO Akero Therapeutics
Gangloff Scott A. / officer: Chief Technology Officer
12/16/2024
Buy
$29.23
73,700
$2.154M
73,700
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/17/2024
Buy
$19.87
3,800
$76K
182,137
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/17/2024
Sell
$31.10
3,800
$118K
178,337
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/17/2024
Sell
$19.87
3,800
$76K
134,955
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/16/2024
Buy
$29.23
60,000
$1.754M
60,000
NASDAQ AKRO Akero Therapeutics
Cheng Andrew / director, officer: President and CEO
12/16/2024
Buy
$29.23
295,600
$8.640M
295,600
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/10/2024
Buy
$19.87
2,450
$49K
180,787
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/10/2024
Sell
$31.03
2,450
$76K
178,337
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/10/2024
Sell
$30.79
2,368
$73K
178,337
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/10/2024
Sell
$19.87
2,450
$49K
138,755
NASDAQ AKRO Akero Therapeutics
Young Jonathan / officer: Chief Operating Officer
12/10/2024
Sell
$30.79
2,503
$77K
203,783
NASDAQ AKRO Akero Therapeutics
Lamy Patrick / officer: Senior VP, Commercial Strategy
12/10/2024
Sell
$30.79
925
$28K
17,858
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
12/10/2024
Sell
$30.79
2,810
$87K
71,348
NASDAQ AKRO Akero Therapeutics
White William Richard / officer: Chief Financial Officer
12/10/2024
Sell
$30.79
2,817
$87K
38,335
NASDAQ AKRO Akero Therapeutics
Cheng Andrew / director, officer: President and CEO
12/10/2024
Sell
$30.79
7,855
$242K
597,562
NASDAQ AKRO Akero Therapeutics
Cheng Andrew / director, officer: President and CEO
12/02/2024
Buy
$21.10
25,000
$528K
630,417
NASDAQ AKRO Akero Therapeutics
Cheng Andrew / director, officer: President and CEO
12/02/2024
Sell
$32.09
25,000
$802K
605,417
NASDAQ AKRO Akero Therapeutics
Cheng Andrew / director, officer: President and CEO
12/02/2024
Sell
$21.10
25,000
$528K
111,029
NASDAQ AKRO Akero Therapeutics
Young Jonathan / officer: Chief Operating Officer
12/02/2024
Sell
$32.13
10,000
$321K
206,286
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
11/15/2024
Buy
$21.10
9,061
$191K
83,219
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
11/15/2024
Sell
$27.69
8,761
$243K
74,458
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
11/15/2024
Sell
$28.82
300
$9K
74,158
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
11/15/2024
Sell
$21.10
9,061
$191K
53,421